Radiotherapy after hyperbaric oxygenation for malignant gliomas: a pilot study

Area of Science:

• Oncology
• Radiotherapy
• Hyperbaric Medicine

Background:

• Malignant gliomas are aggressive brain tumors with poor prognoses.
• Standard radiotherapy offers limited efficacy for these tumors.
• Hyperbaric oxygen therapy (HBOT) has shown potential in enhancing radiation effects.

Purpose of the Study:

• To evaluate the efficacy of radiotherapy combined with hyperbaric oxygen (HBOT) in patients with malignant glioma.
• To compare outcomes of this combined treatment with radiotherapy alone.
• To report the initial findings of a pilot study on this novel therapeutic regimen.

Main Methods:

• A pilot study comparing 9 patients receiving radiotherapy with HBOT to 12 patients receiving radiotherapy alone.
• Irradiation was administered immediately following hyperbaric oxygen exposure.
• Tumor response was assessed by measuring regression in size.

Main Results:

• All 9 patients treated with radiotherapy and HBOT demonstrated over 50% tumor regression.
• Complete tumor disappearance was observed in 4 of the 9 patients in the combined treatment group.
• Only 4 of 12 patients receiving radiotherapy alone showed tumor size reduction, and all died within 36 months.

Conclusions:

• Radiotherapy combined with hyperbaric oxygen appears to be an effective treatment for malignant gliomas.
• This combined regimen shows superior outcomes compared to radiotherapy alone.
• Further investigation is warranted to confirm the utility of this novel approach in managing malignant gliomas.